FibroBiologics has been granted a European patent for a method that modifies fibroblasts to deliver anti-cancer agents directly to tumors. This technology enhances fibroblasts' natural ability to home to cancer cells and carry agents like oncolytic viruses, improving targeted cancer treatment while minimizing harm to healthy tissue. The patent covers various tumor-inhibiting payloads and supports use alongside existing cancer therapies. This innovation could advance cancer treatment by concentrating therapies within tumors more effectively.
FibroBiologics patent news comes with a strong health sector showing on Pluang: 87 of 150 priced US health stocks rose as of Nov 05, 2026 19:42 WIB. For readers following health stocks, notable movers include NVAX at USD 11.21 with a 5.31% gain and 84% buy orders, IOVA at USD 9.13 up 4.94% with nearly balanced buy/sell activity, and ALNY at USD 168.00 rising 4.30% despite 89% sell orders. This snapshot highlights active trading and mixed sentiment in the health sector on Pluang.
Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...
CRCAM Toulouse 31 announced the publication and filing of its financial information report for the quarter ending September 30, 2026. The report is accessible to the public on the company's website under the regulatory information section for 2026. T...
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
